QR код

Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis

Background: Stratifying prostate cancer (PCa) patients into risk groups at time of initial diagnosis enabling a risk-adapted disease management is still a major clinical challenge. Existing studies evaluating the prognostic potential of PSMA (prostate-specific membrane antigen) for PCa were performe...

Повний опис

Збережено в:
Автори: Marie Christine Hupe, Christian Philippi, Doris Roth, Christiane Kümpers, Julika Ribbat-Idel, Finn Becker, Vincent Joerg, Stefan Duensing, Verena Helena Lubczyk, Jutta Kirfel, Verena Sailer, Rainer Kuefer, Axel Stuart Merseburger, Sven Perner, Anne Offermann
Формат: Artigo
Мова:Inglês
Опубліковано: Frontiers Media S.A. 2018-12-01
Серія:Frontiers in Oncology
Предмети:
disease recurrence
immunohistochemistry
prognostic biomarker
prostate biopsy
prostate cancer
prostate-specific membrane antigen
Онлайн доступ:https://www.frontiersin.org/article/10.3389/fonc.2018.00623/full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси